Citigroup’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | -$53 | – | 5081 |
|
|
2022
Q4 | $53 | Buy |
+100
| New | +$53 | ﹤0.01% | 4856 |
|
|
2022
Q3 | – | Sell |
-138
| Closed | – | – | 5623 |
|
|
2022
Q2 | $0 | Buy |
+138
| New | – | ﹤0.01% | 5903 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$3K | – | 5608 |
|
|
2021
Q2 | $3K | Hold |
500
| – | – | ﹤0.01% | 5264 |
|
|
2021
Q1 | $2K | Sell |
500
-500
| -50% | -$2K | ﹤0.01% | 5394 |
|
|
2020
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 5088 |
|
|
2020
Q3 | $3K | Sell |
1,000
-1,707
| -63% | -$5.12K | ﹤0.01% | 4874 |
|
|
2020
Q2 | $9K | Sell |
2,707
-4,499
| -62% | -$15K | ﹤0.01% | 4691 |
|
|
2020
Q1 | $28K | Buy |
7,206
+266
| +4% | +$1.03K | ﹤0.01% | 4189 |
|
|
2019
Q4 | $42K | Buy |
6,940
+3,352
| +93% | +$20.3K | ﹤0.01% | 4084 |
|
|
2019
Q3 | $27K | Buy |
3,588
+3,068
| +590% | +$23.1K | ﹤0.01% | 4112 |
|
|
2019
Q2 | $7K | Buy |
520
+20
| +4% | +$269 | ﹤0.01% | 4830 |
|
|
2019
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 4949 |
|
|
2018
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 4971 |
|
|
2018
Q3 | $4K | Hold |
500
| – | – | ﹤0.01% | 4863 |
|
|
2018
Q2 | $5K | Sell |
500
-12
| -2% | -$120 | ﹤0.01% | 4763 |
|
|
2018
Q1 | $4K | Sell |
512
-173
| -25% | -$1.35K | ﹤0.01% | 4668 |
|
|
2017
Q4 | $9K | Sell |
685
-4,227
| -86% | -$55.5K | ﹤0.01% | 4545 |
|
|
2017
Q3 | $41K | Sell |
4,912
-216,786
| -98% | -$1.81M | ﹤0.01% | 3743 |
|
|
2017
Q2 | $3.76M | Buy |
221,698
+220,068
| +13,501% | +$3.73M | ﹤0.01% | 1101 |
|
|
2017
Q1 | $33K | Buy |
1,630
+630
| +63% | +$12.8K | ﹤0.01% | 3871 |
|
|
2016
Q4 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 4445 |
|
|
2016
Q3 | $13K | Buy |
+1,000
| New | +$13K | ﹤0.01% | 4348 |
|
|
2016
Q2 | – | Sell |
-2,562
| Closed | -$24K | – | 5361 |
|
|
2016
Q1 | $24K | Buy |
2,562
+1,493
| +140% | +$14K | ﹤0.01% | 4539 |
|
|
2015
Q4 | $10K | Buy |
+1,069
| New | +$10K | ﹤0.01% | 4793 |
|